We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.9B
AUM Growth
+$404M
(+1%)
Cap. Flow
-$1.26B
Cap. Flow
% of AUM
-3.07%
Top 10 Holdings %
Top 10 Hldgs %
14.11%
Holding
812
New
105
Increased
224
Reduced
322
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$166M |
| 2 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$149M |
| 3 |
AbbVie
ABBV
|
+$148M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$129M |
| 5 |
CFN
CAREFUSION CORPORATION
CFN
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$846M |
| 2 |
Stanley Black & Decker
SWK
|
+$190M |
| 3 |
Citigroup
C
|
+$156M |
| 4 |
CNQR
CONCUR TECHNOLOGIES INC
CNQR
|
+$151M |
| 5 |
Air Products & Chemicals
APD
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 12.19% |
| 3 | Financials | 11% |
| 4 | Industrials | 9.4% |
| 5 | Consumer Staples | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Raymond James Financial
RJF
$33.8B
| $2.87M | 0.01% |
75,000
| – | – |
|
|
KND
652
DELISTED
Kindred Healthcare
KND
| $2.73M | 0.01% |
150,000
-250,000
| -63% | -$4.95M |
|
|
VASC
653
DELISTED
Vascular Solutions Inc
VASC
| $2.72M | 0.01% |
+100,000
| New | +$2.71M |
|
654
United Airlines
UAL
$39.7B
| $2.68M | 0.01% |
+40,000
| New | +$2.22M |
|
655
Nexstar Media Group
NXST
$5.83B
| $2.59M | 0.01% |
+50,000
| New | +$2.31M |
|
|
INFI
656
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $2.53M | 0.01% |
150,000
-450,000
| -75% | -$6.55M |
|
|
RIGP
657
DELISTED
Transocean Partners LLC
RIGP
| $2.39M | 0.01% |
+163,349
| New | +$3.33M |
|
|
CTRA
658
DELISTED
Coterra Energy
CTRA
| $2.37M | 0.01% |
80,150
-91,000
| -53% | -$2.86M |
|
659
CareCloud
CCLD
$105M
| $2.35M | 0.01% |
1,005,000
| – | – |
|
660
Under Armour
UAA
$2.86B
| $2.24M | 0.01% |
66,468
-411,702
| -86% | -$13.8M |
|
|
ICEL
661
DELISTED
CELLULAR DYNAMICS INTL INC COM STK (WI)
ICEL
| $2.2M | 0.01% |
342,000
| – | – |
|
|
DSCI
662
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $2.18M | 0.01% |
234,442
+159,442
| +213% | +$1.39M |
|
|
B
663
Barrick Mining
B
$61.6B
| $2.16M | 0.01% |
200,000
| – | – |
|
664
First Horizon
FHN
$12.1B
| $2.04M | 0.01% |
150,200
+100,000
| +199% | +$1.27M |
|
|
VIRX
665
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.99M | ﹤0.01% |
+3,706
| New | +$1.67M |
|
|
SUSQ
666
DELISTED
SUSQUEHANNA BANCSHARES INC
SUSQ
| $1.88M | ﹤0.01% |
+140,000
| New | +$1.63M |
|
|
CASC
667
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.8M | ﹤0.01% |
158,333
| – | – |
|
668
Leidos
LDOS
$14.2B
| $1.8M | ﹤0.01% |
41,399
-96,785
| -70% | -$3.79M |
|
|
WFT
669
DELISTED
Weatherford International plc
WFT
| $1.72M | ﹤0.01% |
150,000
-150,000
| -50% | -$2.25M |
|
670
Occidental Petroleum
OXY
$55.8B
| $1.64M | ﹤0.01% |
20,435
-958,730
| -98% | -$79.6M |
|
671
ATI
ATI
$25.7B
| $1.64M | ﹤0.01% |
47,100
-67,100
| -59% | -$2.22M |
|
|
JNS
672
DELISTED
Janus Capital Group Inc
JNS
| $1.61M | ﹤0.01% |
+100,000
| New | +$1.5M |
|
673
BlueLinx
BXC
$415M
| $1.58M | ﹤0.01% |
136,300
| – | – |
|
|
TLM
674
DELISTED
TALISMAN ENERGY INC
TLM
| $1.57M | ﹤0.01% |
+200,000
| New | +$1.26M |
|
|
DS
675
DELISTED
Drive Shack Inc.
DS
| $1.35M | ﹤0.01% |
300,000
-1,177,375
| -80% | -$5.41M |
|
Similar funds
Adage Capital Partners's Q4 2014 Portfolio in Review
As of Q4 2014, Adage Capital Partners held 812 positions worth $40.9B, up 1% from $40.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Adage Capital Partners withdrew a net $1.26B in Q4 2014, closing 106 positions and reducing 322 holdings. Its most notable exit was Shire pic, an estimated $846M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in AbbVie worth $154M.
- Adage Capital Partners's largest Q4 2014 buy was AbbVie: 2,352,875 shares worth $154M.
- Adage Capital Partners added most to Allergan Inc in Q4 2014, an estimated $166M increase.
- Adage Capital Partners's biggest Q4 2014 reduction was Stanley Black & Decker, cutting an estimated $190M.
- Adage Capital Partners fully exited Shire pic in Q4 2014, selling an estimated $846M.
- Adage Capital Partners's ten largest holdings make up 14% of its $40.9B portfolio in Q4 2014.
- Adage Capital Partners opened 105 new positions and closed 106 in Q4 2014.
- Adage Capital Partners's portfolio value rose 1% quarter-over-quarter to $40.9B.
Based on Adage Capital Partners's 13F filing for Q4 2014, filed 17 Feb 2015.